Asthma
Improve breathing and reduce asthma symptoms through respiratory acupuncture.
Asthma is a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early morning. These symptoms result from variable and widespread airflow obstruction that is often reversible, either spontaneously or with treatment. Asthma affects approximately 300 million people worldwide (about 8–10% of adults and higher in children), with prevalence increasing in many regions due to environmental factors. It is a heterogeneous condition with different phenotypes (e.g., allergic, non-allergic, eosinophilic, obesity-related, exercise-induced).
Symptoms
Wheezing (high-pitched whistling during exhalation).
Shortness of breath or difficulty breathing.
Chest tightness or pressure.
Cough (often dry, persistent, worse at night or with triggers).
Symptoms episodic or persistent, triggered by allergens, exercise, cold air, respiratory infections, irritants (smoke, pollution), stress, or weather changes.
In severe exacerbations: Rapid breathing, accessory muscle use, cyanosis, inability to speak in sentences.
Causes and Contributing Factors
Airway inflammation: Chronic eosinophilic or neutrophilic inflammation, mucus hypersecretion, bronchial hyperresponsiveness.
Genetic predisposition + environmental triggers: Allergens (pollen, dust mites, pet dander), air pollution, tobacco smoke, occupational exposures, viral infections, obesity.
Immune dysregulation: Th2-dominant response in allergic asthma (elevated IgE, cytokines IL-4/IL-5/IL-13), mast cell activation, airway remodeling in chronic cases.
Risk factors: Family history, early-life exposures (e.g., infections, antibiotics), urban living, smoking.
Diagnosis
Clinical history + spirometry (reversible airflow obstruction: FEV1 increase ≥12% and 200 mL post-bronchodilator), peak flow variability, bronchial provocation tests if needed. Biomarkers: Fractional exhaled nitric oxide (FeNO), blood/sputum eosinophils, IgE. Classify severity/control using GINA guidelines (symptom frequency, exacerbations, lung function).
Complications
Frequent exacerbations/hospitalizations, airway remodeling (fixed obstruction), reduced quality of life, side effects from long-term corticosteroids (osteoporosis, growth suppression in children), increased risk of COPD overlap, mortality in severe uncontrolled cases.
Conventional Management
Per GINA guidelines: Stepwise approach—controller medications (inhaled corticosteroids [ICS] first-line, add LABA, LTRA, biologics [omalizumab, mepolizumab] for severe), reliever (SABA or ICS-formoterol). Avoidance of triggers, action plans, education, vaccination (flu/pneumococcal), smoking cessation. Biologics for eosinophilic/allergic severe asthma.
How Acupuncture Helps
Acupuncture is a safe, non-pharmacological complementary therapy used as an adjunct for asthma, particularly to reduce symptoms, exacerbations, and medication reliance. In Traditional Chinese Medicine (TCM), asthma (often "Xiao Chuan" — wheezing/breathlessness) involves Lung Qi deficiency (weak defensive Qi failing to protect airways), external Wind-Cold/Heat invasion (triggers causing acute attacks), phlegm-damp accumulation (mucus obstruction), Liver Qi stagnation (stress/emotional factors), or Kidney deficiency (chronic root weakness). Acupuncture tonifies Lung Qi, descends rebellious Qi, resolves phlegm, expels pathogenic factors, soothes Liver, and strengthens defensive Wei Qi to improve breathing, reduce inflammation, and harmonize the respiratory system.
From a modern Western perspective, acupuncture modulates:
Airway inflammation: Reduces Th2 cytokines (IL-4, IL-5, IL-13), lowers IgE, inhibits mast cell degranulation/histamine release, decreases eosinophil infiltration.
Bronchial hyperresponsiveness: Improves airway smooth muscle relaxation, enhances mucociliary clearance.
Immune balance: Shifts Th1/Th2 toward Th1 dominance, modulates regulatory T cells.
Lung function: Increases FEV1%, peak flow, reduces symptom scores/exacerbations.
Autonomic regulation: Boosts parasympathetic tone, reduces sympathetic overdrive/stress response.
Symptom relief: Alleviates wheezing, cough, dyspnea via central nervous system effects and endorphin release.
Common acupoints include LU7 (Lieque) (Lung opening, releases exterior), LU9 (Taiyuan) (Lung Qi tonification), BL13 (Feishu) (Lung Shu), CV17 (Tanzhong) (chest/respiration), ST36 (Zusanli) (Qi/energy boost), LI4 (Hegu) (Wind expulsion), GV14 (Yang points for heat), plus extras like Dingchuan (asthma point) — often with electroacupuncture (low frequency for anti-inflammatory effects), moxibustion (warming for deficiency/cold patterns), or auricular points.
Clinical Evidence Recent systematic reviews, meta-analyses, and RCTs (up to 2025–2026) support acupuncture's adjunctive benefits:
Overall efficacy: 2025 systematic review/meta-analysis (14 reviews included): Acupuncture therapies significantly improved total efficacy rate (RR 1.11, 95% CI 1.03–1.20, low heterogeneity), symptom relief, and some pulmonary function parameters vs. controls; low-moderate evidence quality, safety reporting limited but no serious AEs noted.
Adult asthma: 2023 sham/placebo-controlled meta-analysis (16 RCTs): Improved FEV1% (MD 6.11), quality of life (AQLQ MD 7.26), symptom scores (SMD -2.73), asthma control (ACT increase), reduced exacerbations (MD -1.00/year); moderate-quality evidence for key outcomes.
Pediatric asthma: 2025 meta-analysis: Positive effects on certain immune/inflammatory biomarkers and FEV1; mixed on overall symptoms, but promising as adjunct.
Mechanistic insights: Reviews (2024) highlight modulation of airway inflammation, Th1/Th2 balance, mast cells, and immune function.
Safety: Excellent—no serious adverse events reported; mild/transient (soreness) rare, often better tolerated than some medications.
Other: Promising in cough-variant asthma (ongoing 2025–2026 pilot RCT protocols), acute exacerbations (related COPD data supportive).
Evidence quality: Low to moderate (heterogeneity, blinding challenges, variable sham controls), but consistent positives in recent 2025 meta-analyses for symptom relief, lung function, and adjunctive role; especially valuable for mild-moderate or medication-intolerant patients.
Typical treatment duration: 8-12 sessions
Ready to explore treatment for Asthma?
Schedule a consultation to discuss how acupuncture can help you.